Sign in to continue:

Wednesday, April 22nd, 2026

宁夏英力特化工股份有限公司2025年度利润分配预案公告:不派发现金红利,未分配利润为负

宁夏英力特化工股份有限公司2025年度利润分配预案详细解读

宁夏英力特化工股份有限公司2025年度利润分配预案详细解读


一、公告摘要

宁夏英力特化工股份有限公司(证券代码:000635,证券简称:英力特)于2026年4月21日披露了《关于2025年度利润分配预案的公告》。公司董事会已审议通过此预案,现将具体内容详细解读如下:

二、关键内容与投资者须知

  • 2025年度不进行利润分配:公司2025年度拟不派发现金红利、不送红股、不以资本公积金转增股本。
  • 主要原因:2025年度公司归属于上市公司股东的净利润为-553,556,379.96元,且期末可供分配利润为-1,757,478,499.29元,均为负值,无法满足相关法律法规及公司章程关于利润分配的条件。
  • 连续三年未分红:公司2023、2024、2025年度累计现金分红和回购注销总额均为0元,三年平均净利润为负值(-574,628,451.64元),显示公司已连续三年未分红。
  • 财务状况持续恶化:公司连续三年净利润为负,且累计未分配利润持续为负,反映出公司经营压力较大,已进入亏损状态。
  • 合规性及董事意见:公司独立董事明确表示,利润分配预案符合相关法律法规和公司章程,不存在损害公司股东(尤其是中小股东)利益的情况。
  • 后续审议流程:该预案还需提交公司2025年度股东大会审议。
  • 风险警示:公司未触及《股票上市规则》第9.8.1条第(九)项规定的其他风险警示情形。

三、对投资者和股价可能产生的影响

对于投资者而言:

  • 公司连续亏损且未分红,可能影响投资者信心,导致股价承压。
  • 公司财务状况恶化,未来分红能力受限,短期内难以实现股东回报。
  • 虽然未触及风险警示条款,但长期亏损可能影响公司估值与市场表现。
  • 投资者需关注公司后续经营改善及利润恢复情况,警惕可能的风险。

四、备查文件

  • 2025年度审计报告
  • 董事会决议
  • 独立董事会议决议

免责声明

本报道仅为信息披露解读,不构成投资建议。投资者需结合自身情况、市场环境及公司最新公告作出判断。公司未来业绩及股价存在不确定性,投资请谨慎。


English Version


Detailed Analysis of Ningxia Yinglite Chemical Co., Ltd. 2025 Profit Distribution Proposal


1. Summary

Ningxia Yinglite Chemical Co., Ltd. (Stock Code: 000635) disclosed the “2025 Profit Distribution Proposal” on April 21, 2026. The board has passed this proposal, and the following is a detailed breakdown:

2. Key Points & Investor Information

  • No Profit Distribution for 2025: The company plans no cash dividends, bonus shares, or capital reserve capitalization for 2025.
  • Main Reason: Net profit attributable to shareholders in 2025 is -553,556,379.96 yuan. Distributable profit at year-end is -1,757,478,499.29 yuan. Both are negative, not meeting legal and charter requirements for profit distribution.
  • No Dividends for Three Consecutive Years: For 2023, 2024, and 2025, both cash dividends and share repurchases are zero. The average net profit over three years is negative (-574,628,451.64 yuan), showing persistent losses.
  • Worsening Financials: The company is in a sustained loss, with accumulated undistributed profits in the negative, indicating significant operating pressure.
  • Compliance & Board Opinion: Independent directors confirm the proposal complies with laws, regulations, and the company charter, and does not harm shareholders’ interests, especially minority shareholders.
  • Further Review: The proposal still needs to be submitted to the 2025 Annual Shareholders Meeting for approval.
  • Risk Warning: The company has not triggered other risk warning clauses under Listing Rule 9.8.1(9).

3. Potential Impact on Investors and Share Price

For investors:

  • Continuous losses and no dividends may erode investor confidence and pressure the share price.
  • With deteriorating financials, future dividend capability is limited, and shareholder returns are unlikely in the short term.
  • Although no risk warning is triggered, prolonged losses may affect valuation and market performance.
  • Investors should monitor the company’s operational turnaround and profit recovery, and be aware of associated risks.

4. Reference Documents

  • 2025 Audit Report
  • Board Resolution
  • Independent Directors’ Meeting Resolution

Disclaimer

This report is for information disclosure interpretation only and does not constitute investment advice. Investors should make their own judgments based on their circumstances, market environment, and the latest company announcements. Future performance and share price are uncertain—invest prudently.


View 英 力 特 Historical chart here



*ST大立2025年度拟不进行利润分配公告:净利润为负不符分红条件

浙江大立科技股份有限公司2025年度拟不进行利润分配公告详解 摘要:浙江大立科技股份有限公司(证券代码:002214,简...

漱玉平民大药房为全资子公司提供担保进展公告(2026年最新)

详细内容解读 1. 担保事项概述 公司于2026年1月和2月分别召开董事会和股东大会,审议通过了2026年度...

深圳市美好创亿医疗科技股份有限公司2025年度利润分配及资本公积转增股本预案公告

美好医疗(301363):发布2025年度利润分配及资本公积转增股本预案 重点内容解读 2025年度利润分配及资本公积...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today